{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T08:51:36Z","timestamp":1778316696203,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004410","name":"Scientific and Technological Research Council Turkey","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jmgm.2020.107727","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T17:34:38Z","timestamp":1598981678000},"page":"107727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Potent novel inhibitors against hepatitis C virus NS3 (HCV NS3 GT-3a) protease domain"],"prefix":"10.1016","volume":"101","author":[{"given":"Saima","family":"Ikram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamshaid","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irshad-Ur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serdar","family":"Durdagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jmgm.2020.107727_bib1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4254\/wjh.v7.i3.327","article-title":"Hepatitis C virus syndrome: a constellation of organ-and non-organ specific autoimmune disorders, B-cell non-Hodgkin\u2019s lymphoma, and cancer","volume":"7","author":"Ferri","year":"2015","journal-title":"World J. Hepatol."},{"issue":"2","key":"10.1016\/j.jmgm.2020.107727_bib2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.canlet.2013.06.028","article-title":"Mechanisms of HCV-induced liver cancer: what did we learn from in\u00a0vitro and animal studies?","volume":"345","author":"Rusyn","year":"2014","journal-title":"Canc. Lett."},{"issue":"1","key":"10.1016\/j.jmgm.2020.107727_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/v11010030","article-title":"Overview of HCV life cycle with a special focus on current and possible future antiviral targets","volume":"11","author":"Alazard-Dany","year":"2019","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.jmgm.2020.107727_bib4","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1006\/bbrc.1996.1225","article-title":"Characterization of RNA binding activity and RNA helicase activity of the hepatitis C virus NS3 protein","volume":"225","author":"Gwack","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.jmgm.2020.107727_bib5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource","volume":"59","author":"Smith","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jmgm.2020.107727_bib6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jviromet.2015.05.013","article-title":"Rapid detection of HCV genotyping 1a, 1b, 2a, 3a, 3b and 6a in a single reaction using two-melting temperature codes by a real-time PCR-based assay","volume":"222","author":"Athar","year":"2015","journal-title":"J.\u00a0Virol Methods"},{"issue":"1","key":"10.1016\/j.jmgm.2020.107727_bib7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.27259","article-title":"Global distribution and prevalence of hepatitis C virus genotypes","volume":"61","author":"Messina","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jmgm.2020.107727_bib8","series-title":"\u00a9 1995 by Thieme Seminars in Liver Disease","article-title":"Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes","author":"Bukh","year":"1995"},{"issue":"1","key":"10.1016\/j.jmgm.2020.107727_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1479-0556-9-7","article-title":"In-vitro model systems to study Hepatitis C Virus","volume":"9","author":"Ashfaq","year":"2011","journal-title":"Genet. Vaccine Ther."},{"issue":"2","key":"10.1016\/j.jmgm.2020.107727_bib10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/bib\/5.2.150","article-title":"MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment","volume":"5","author":"Kumar","year":"2004","journal-title":"Briefings Bioinf."},{"issue":"11","key":"10.1016\/j.jmgm.2020.107727_bib11","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0969-2126(00)80025-8","article-title":"Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease\u2013helicase","volume":"7","author":"Yao","year":"1999","journal-title":"Structure"},{"issue":"1","key":"10.1016\/j.jmgm.2020.107727_bib12","doi-asserted-by":"crossref","first-page":"5.6. 1","DOI":"10.1002\/0471250953.bi0506s47","article-title":"Comparative protein structure modeling using MODELLER","volume":"47","author":"Webb","year":"2014","journal-title":"Curr. Protoc. Bioinf."},{"issue":"2","key":"10.1016\/j.jmgm.2020.107727_bib13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J.\u00a0Appl. Crystallogr."},{"issue":"3","key":"10.1016\/j.jmgm.2020.107727_bib14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J.\u00a0Comput. Aided Mol. Des."},{"issue":"3","key":"10.1016\/j.jmgm.2020.107727_bib15","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/prot.22102","article-title":"Very fast prediction and rationalization of pKa values for protein\u2013ligand complexes","volume":"73","author":"Bas","year":"2008","journal-title":"Proteins: Struct. Funct. Bioinf."},{"issue":"4","key":"10.1016\/j.jmgm.2020.107727_bib16","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/prot.20660","article-title":"Very fast empirical prediction and rationalization of protein pKa values","volume":"61","author":"Li","year":"2005","journal-title":"Proteins: Struct. Funct. Bioinf."},{"issue":"1","key":"10.1016\/j.jmgm.2020.107727_bib17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","article-title":"OPLS3: a force field providing broad coverage of drug-like small molecules and proteins","volume":"12","author":"Harder","year":"2015","journal-title":"J.\u00a0Chem. Theor. Comput."},{"issue":"12","key":"10.1016\/j.jmgm.2020.107727_bib18","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: a software program for pK a prediction and protonation state generation for drug-like molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J.\u00a0Comput. Aided Mol. Des."},{"issue":"6\u20137","key":"10.1016\/j.jmgm.2020.107727_bib19","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10822-010-9349-1","article-title":"Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution","volume":"24","author":"Greenwood","year":"2010","journal-title":"J.\u00a0Comput. Aided Mol. Des."},{"issue":"9","key":"10.1016\/j.jmgm.2020.107727_bib20","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1016\/j.bmc.2005.12.032","article-title":"New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies","volume":"14","author":"Farid","year":"2006","journal-title":"Bioorg. Med. Chem."},{"issue":"10\u201311","key":"10.1016\/j.jmgm.2020.107727_bib21","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10822-006-9087-6","article-title":"PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results","volume":"20","author":"Dixon","year":"2006","journal-title":"J.\u00a0Comput. Aided Mol. Des."},{"issue":"10","key":"10.1016\/j.jmgm.2020.107727_bib22","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1021\/ci900212v","article-title":"Novel method for generating structure-based pharmacophores using energetic analysis","volume":"49","author":"Salam","year":"2009","journal-title":"J.\u00a0Chem. Inf. Model."},{"issue":"8","key":"10.1016\/j.jmgm.2020.107727_bib23","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10822-009-9268-1","article-title":"Energetic analysis of fragment docking and application to structure-based pharmacophore hypothesis generation","volume":"23","author":"Loving","year":"2009","journal-title":"J.\u00a0Comput. Aided Mol. Des."},{"issue":"3","key":"10.1016\/j.jmgm.2020.107727_bib24","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1103\/PhysRevA.31.1695","article-title":"Canonical dynamics: equilibrium phase-space distributions","volume":"31","author":"Hoover","year":"1985","journal-title":"Phys. Rev."},{"issue":"12","key":"10.1016\/j.jmgm.2020.107727_bib25","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1002\/pro.2378","article-title":"The interdomain interface in bifunctional enzyme protein 3\/4A (NS3\/4A) regulates protease and helicase activities","volume":"22","author":"Aydin","year":"2013","journal-title":"Protein Sci."},{"issue":"10\u201311","key":"10.1016\/j.jmgm.2020.107727_bib26","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/00498250600861660","article-title":"Algorithms for network analysis in systems-ADME\/Tox using the MetaCore and MetaDrug platforms","volume":"36","author":"Ekins","year":"2006","journal-title":"Xenobiotica"},{"issue":"13","key":"10.1016\/j.jmgm.2020.107727_bib27","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1016\/j.bmcl.2017.05.001","article-title":"QSAR studies of the bioactivity of hepatitis C virus (HCV) NS3\/4A protease inhibitors by multiple linear regression (MLR) and support vector machine (SVM)","volume":"27","author":"Qin","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"1","key":"10.1016\/j.jmgm.2020.107727_bib28","doi-asserted-by":"crossref","first-page":"6345","DOI":"10.1038\/s41598-017-06612-2","article-title":"Evaluation of Sofosbuvir (\u03b2-D-2\u2032-deoxy-2\u2032-\u03b1-fluoro-2\u2032-\u03b2-C-methyluridine) as an inhibitor of Dengue virus replication","volume":"7","author":"Xu","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.jmgm.2020.107727_bib29","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1590\/1678-4685-GMB-2016-0022","article-title":"Development of a rapid phenotypic test for HCV protease inhibitors with potential use in clinical decisions","volume":"39","author":"Pessoa","year":"2016","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.jmgm.2020.107727_bib30","series-title":"J.\u00a0Intermolecular Forces. B","first-page":"p331","author":"Berendsen","year":"1981"},{"key":"10.1016\/j.jmgm.2020.107727_bib31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jmgm.2018.09.014","article-title":"Targeting the NF-\u03baB\/I\u03baB\u03b1 complex via fragment-based E-Pharmacophore virtual screening and binary QSAR models","volume":"86","author":"Kanan","year":"2019","journal-title":"J.\u00a0Mol. Graph. Model."},{"key":"10.1016\/j.jmgm.2020.107727_bib32","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.antiviral.2014.01.010","article-title":"The competitive binding between inhibitors and substrates of HCV NS3\/4A protease: a general mechanism of drug resistance","volume":"103","author":"Guan","year":"2014","journal-title":"Antivir. Res."},{"issue":"2","key":"10.1016\/j.jmgm.2020.107727_bib33","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1021\/ci400060j","article-title":"Computational study on the drug resistance mechanism against HCV NS3\/4A protease inhibitors vaniprevir and MK-5172 by the combination use of molecular dynamics simulation, residue interaction network, and substrate envelope analysis","volume":"54","author":"Xue","year":"2014","journal-title":"J.\u00a0Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.jmgm.2020.107727_bib34","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.antiviral.2011.11.007","article-title":"Molecular modeling study on the resistance mechanism of HCV NS3\/4A serine protease mutants R155K, A156V and D168A to TMC435","volume":"93","author":"Xue","year":"2012","journal-title":"Antivir. Res."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326320305167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326320305167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:07:07Z","timestamp":1761080827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326320305167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":34,"alternative-id":["S1093326320305167"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2020.107727","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potent novel inhibitors against hepatitis C virus NS3 (HCV NS3 GT-3a) protease domain","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2020.107727","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107727"}}